Skip to main content
SpringerLink
Log in

Ortho Biotech concerned by FDA decision on ESAs

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Ortho Biotech.Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote. Media Release: 13 Mar 2008. Available from: URL: http://www.orthobiotech.com

  2. Ortho Biotech Products L.P..Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia. Media Release: 11 Mar 2008. Available from: URL: http://www.orthobiotech.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ortho Biotech concerned by FDA decision on ESAs. React. Wkly. 1194, 3 (2008). https://doi.org/10.2165/00128415-200811940-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811940-00005

Keywords

Search

Navigation